%0 Journal Article %A White, William B. %A Kowey, Peter %A Diva, Ulysses %A Sostek, Mark %A Tummala, Raj %D 2018 %T Supplemental Material, JCPT_Oct_2016_225_revised_CV_effect_revised_supplemental_materials_24_Jan_2018 - Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation %U https://sage.figshare.com/articles/journal_contribution/Supplementary_Material_JCPT_Oct_2016_225_revised_CV_effect_revised_supplemental_materials_24_Jan_2018_-_Cardiovascular_Safety_of_the_Selective_-Opioid_Receptor_Antagonist_Naloxegol_A_Novel_Therapy_for_Opioid-Induced_Constipation/6371423 %R 10.25384/SAGE.6371423.v2 %2 https://sage.figshare.com/ndownloader/files/11705567 %K naloxegol %K opioid-induced constipation %K cardiovascular safety %K μ-opioid receptor antagonist %K PAMORA %X

Supplemental Material, JCPT_Oct_2016_225_revised_CV_effect_revised_supplemental_materials_24_Jan_2018 for Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation by William B. White, Peter Kowey, Ulysses Diva, Mark Sostek, and Raj Tummala in Journal of Cardiovascular Pharmacology and Therapeutics

%I SAGE Journals